Factors affecting the cleavage efficiency of the CRISPR-Cas9 system

被引:4
|
作者
Jung, Won Jun [1 ,2 ]
Park, Soo-Ji [1 ,2 ]
Cha, Seongkwang [1 ,3 ]
Kim, Kyoungmi [1 ,2 ]
机构
[1] Korea Univ, Coll Med, Dept Physiol, Seoul 02841, South Korea
[2] Korea Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea
[3] Korea Univ, Neurosci Res Inst, Coll Med, Seoul 02841, South Korea
基金
新加坡国家研究基金会;
关键词
CRISPR-Cas9; system; genome editing; cleavage efficiency; sgRNA; chromatin state; STRAND BREAK REPAIR; GENOME MODIFICATION; IMMUNE-SYSTEM; CRISPR/CAS9; CAS9; NUCLEASES; TOOL;
D O I
10.1080/19768354.2024.2322054
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The CRISPR-Cas system stands out as a promising genome editing tool due to its cost-effectiveness and time efficiency compared to other methods. This system has tremendous potential for treating various diseases, including genetic disorders and cancer, and promotes therapeutic research for a wide range of genetic diseases. Additionally, the CRISPR-Cas system simplifies the generation of animal models, offering a more accessible alternative to traditional methods. The CRISPR-Cas9 system can be used to cleave target DNA strands that need to be corrected, causing double-strand breaks (DSBs). DNA with DSBs can then be recovered by the DNA repair pathway that the CRISPR-Cas9 system uses to edit target gene sequences. High cleavage efficiency of the CRISPR-Cas9 system is thus imperative for effective gene editing. Herein, we explore several factors affecting the cleavage efficiency of the CRISPR-Cas9 system. These factors include the GC content of the protospacer-adjacent motif (PAM) proximal and distal regions, single-guide RNA (sgRNA) properties, and chromatin state. These considerations contribute to the efficiency of genome editing.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 50 条
  • [41] CRISPR-Cas9: a world first?
    不详
    LANCET, 2018, 392 (10163): : 2413 - 2413
  • [42] Engineering Genes with CRISPR-Cas9
    Luo, Michelle L.
    Beisel, Chase L.
    CHEMICAL ENGINEERING PROGRESS, 2016, 112 (09) : 36 - 41
  • [43] Protein Inhibitors of CRISPR-Cas9
    Bondy-Denomy, Joseph
    ACS CHEMICAL BIOLOGY, 2018, 13 (02) : 417 - 423
  • [44] Nanoparticles for CRISPR-Cas9 delivery
    Glass, Zachary
    Li, Yamin
    Xu, Qiaobing
    NATURE BIOMEDICAL ENGINEERING, 2017, 1 (11): : 854 - 855
  • [45] Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency
    Dang, Ying
    Jia, Gengxiang
    Choi, Jennie
    Ma, Hongming
    Anaya, Edgar
    Ye, Chunting
    Shankar, Premlata
    Wu, Haoquan
    GENOME BIOLOGY, 2015, 16
  • [46] MicroRNAs tame CRISPR-Cas9
    Jouravleva, Karina
    Zamore, Phillip D.
    NATURE CELL BIOLOGY, 2019, 21 (04) : 416 - 417
  • [47] CRISPR-Cas9 wins Nobel
    Strzyz, Paulina
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (12) : 714 - 714
  • [48] Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency
    Ying Dang
    Gengxiang Jia
    Jennie Choi
    Hongming Ma
    Edgar Anaya
    Chunting Ye
    Premlata Shankar
    Haoquan Wu
    Genome Biology, 16
  • [49] The invisible dance of CRISPR-Cas9
    Palermo, Giulia
    Ricci, Clarisse G.
    McCammon, J. Andrew
    PHYSICS TODAY, 2019, 72 (04) : 30 - 36
  • [50] CRISPR-Cas9 in cancer therapeutics
    Randhawa, Shubhchintan
    REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 129 - 163